What's Happening?
Mozza Foods, a California-based molecular farming startup, is targeting a late 2028 launch for its soybean-grown casein, pending USDA and FDA approvals. The company, co-founded by Adam Tarshis and Cory Tobin, focuses on producing dairy proteins from genetically
modified soybeans. Mozza aims to achieve cost parity with traditional dairy by leveraging existing soybean and dairy processing infrastructure. The company has conducted field trials and is working to improve expression levels of casein proteins in soybeans. Mozza's approach involves producing casein micelles directly in the seed, which simplifies downstream processing and reduces costs. The company is also developing a crop segregation system to ensure identity preservation and compliance with regulatory standards.
Why It's Important?
Mozza Foods' initiative represents a significant advancement in the alternative protein sector, offering a sustainable and cost-effective solution to traditional dairy production. By utilizing molecular farming, Mozza can potentially reduce reliance on animal agriculture, addressing environmental and ethical concerns. The company's focus on achieving cost parity is crucial for widespread adoption and market competitiveness. If successful, Mozza's soybean-grown casein could transform the dairy industry, providing a viable alternative that meets consumer demand for sustainable and ethical products.
What's Next?
Mozza Foods is expected to continue its efforts to improve casein expression levels and secure regulatory approvals. The company plans to submit a GRAS application to the FDA and anticipates USDA approval for growing its GM crops. As Mozza progresses, it will likely focus on scaling production and expanding its market reach. The company's success could pave the way for further innovations in molecular farming and alternative proteins, potentially reshaping the food industry and reducing the environmental impact of traditional agriculture.
